Skin of ColorSOCU Poster Abstracts

Twenty Nail Dystrophy; a case report from Disharc, Nepal

By June 12, 2020July 1st, 2020No Comments

Skin of Color Update

Featured Poster Abstract

The following is a selected scientific poster abstract from the 2019 Skin of Color Update.

Learn More

"Twenty Nail Dystrophy; a case report from Disharc, Nepal"

Author: Prarthana Adhikari, MD

The following is a selected scientific poster abstract from the 2019 Skin of Color Update.

Twenty-nail dystrophy (TND) is rare and less reported chronic inflammatory disorder affecting nail matrix of all twenty nails. Literature reports mainly as idiopathic but are also associated with cutaneous or systemic disorders among childhood. It clinically presents as rough, thin, brittle lustureless nails with multiple pits. The diagnosis was made clinically but pathological study shows spongiosis and exocytosis of inflammatory cells in epithelium.

Case Report: We present a case of 9-year-old boy with complaints of rough, thin and pitted nails. He was asymptomatic but was under antithyroid medication for hypothyroidism. His only concern was bad appearance. He was given mild topical steroids and emollients. After 6 months of follow-up, patient has shown sign of improvement. Therefore, TND can also be inferenced as self-limiting disease with minimum treatment can have positive reference.

Skin of Color Scientific Poster Abstracts

View a curated selection of scientific poster abstracts from the Skin of Color Update conference below.

Explore More

Skin of Color Update Virtual

The Experts’ Forum for Multicultural Dermatology

The US population is growing and evolving and the clinical profile of the average patient presenting to the dermatologist is changing. One in three Americans self-identify as member of a non-caucasian racial or ethnic group. Data shows as of 2020, individuals of non-Caucasian, multi-racial descent will comprise more than 50% of the population.

Skin of Color Update Virtual 2020 Topics

 

  • Hair Loss
  • Acne
  • Rosacea
  • Skin Care with Cosmeceuticals
  • PRP
  • Psoriasis
  • Scalp Psoriasis
  • Skin Cancer
  • and more!
Register for SOCU 2020 Now

You May Also Like

Journal of Drugs in Dermatology JDD featuring Dr. Jacob Beer in JDD Re:View, a discussion of JDD articles and specific topics. This article highlights Aesthetics Is Changing. Here’s What We’re Seeing?

JDD Re:View With Dr. Beer

| Aesthetics, Featured Articles, JDD Re:View, Latest News | No Comments
Aesthetics Is Changing. Here’s What We’re Seeing? Most dermatologists have experienced a shift in patient preferences over the past several years. There is a shift toward a minimalist, natural appearance.…
Journal of Drugs in Dermatology JDD Article about Racial Disparities in United States Clinical Trial Enrollment for Mycosis Fungoides and Sézary Syndrome

Racial Disparities in United States Clinical Trial Enrollment for Mycosis Fungoides and Sézary Syndrome

| Featured Articles, Latest News, Skin of Color | No Comments
Trials fall short on representation - Black patients underenrolled in MF/SS studies The February issue of JDD features a review of completed US interventional trials for mycosis fungoides and Sézary syndrome…
Journal of Drugs in Dermatology JDD Article about Dual IL-17A/F Blockade for Acrodermatitis Continua of Hallopeau: A Clinical Response to Bimekizumab. Image shows thumb and nail or patient.

Dual IL-17A/F Blockade for Acrodermatitis Continua of Hallopeau: A Clinical Response to Bimekizumab

| Case Reports, Featured Articles, Latest News | No Comments
Case report shows dual IL‑17A/F blockade produced striking clinical and functional gains within one month in refractory ACH The February 2026 JDD issue features a case report about a 67‑year‑old…

Leave a Reply